Literature DB >> 22123926

p53 negatively regulates transcription of the pyruvate dehydrogenase kinase Pdk2.

Tanupriya Contractor1, Chris R Harris.   

Abstract

In cancer cells, the aberrant conversion of pyruvate into lactate instead of acetyl-CoA in the presence of oxygen is known as the Warburg effect. The consequences and mechanisms of this metabolic peculiarity are incompletely understood. Here we report that p53 status is a key determinant of the Warburg effect. Wild-type p53 expression decreased levels of pyruvate dehydrogenase kinase-2 (Pdk2) and the product of its activity, the inactive form of the pyruvate dehydrogenase complex (P-Pdc), both of which are key regulators of pyruvate metabolism. Decreased levels of Pdk2 and P-Pdc in turn promoted conversion of pyruvate into acetyl-CoA instead of lactate. Thus, wild-type p53 limited lactate production in cancer cells unless Pdk2 could be elevated. Together, our results established that wild-type p53 prevents manifestation of the Warburg effect by controlling Pdk2. These findings elucidate a new mechanism by which p53 suppresses tumorigenesis acting at the level of cancer cell metabolism.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22123926     DOI: 10.1158/0008-5472.CAN-11-1215

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  95 in total

1.  Acute Tumor Lactate Perturbations as a Biomarker of Genotoxic Stress: Development of a Biochemical Model.

Authors:  Vlad C Sandulache; Yunyun Chen; Heath D Skinner; Tongtong Lu; Lei Feng; Laurence E Court; Jeffrey N Myers; Raymond E Meyn; Clifton D Fuller; James A Bankson; Stephen Y Lai
Journal:  Mol Cancer Ther       Date:  2015-09-16       Impact factor: 6.261

2.  Cited2 is required for the maintenance of glycolytic metabolism in adult hematopoietic stem cells.

Authors:  Jinwei Du; Qiang Li; Fangqiang Tang; Michelle A Puchowitz; Hisashi Fujioka; Sally L Dunwoodie; David Danielpour; Yu-Chung Yang
Journal:  Stem Cells Dev       Date:  2013-11-12       Impact factor: 3.272

Review 3.  Two-way communication between the metabolic and cell cycle machineries: the molecular basis.

Authors:  Joanna Kaplon; Loes van Dam; Daniel Peeper
Journal:  Cell Cycle       Date:  2015       Impact factor: 4.534

Review 4.  Metabolic modulation of cancer: a new frontier with great translational potential.

Authors:  Adam Kinnaird; Evangelos D Michelakis
Journal:  J Mol Med (Berl)       Date:  2015-01-14       Impact factor: 4.599

5.  Co-culture With Human Breast Adipocytes Differentially Regulates Protein Abundance in Breast Cancer Cells.

Authors:  Rebekah Lee Isla Crake; Elisabeth Phillips; Torsten Kleffmann; Margaret Jane Currie
Journal:  Cancer Genomics Proteomics       Date:  2019 Sep-Oct       Impact factor: 4.069

Review 6.  p53 and mitochondrial function in neurons.

Authors:  David B Wang; Chizuru Kinoshita; Yoshito Kinoshita; Richard S Morrison
Journal:  Biochim Biophys Acta       Date:  2014-01-08

Review 7.  Regulation of pyruvate metabolism in metabolic-related diseases.

Authors:  Nam Ho Jeoung; Chris R Harris; Robert A Harris
Journal:  Rev Endocr Metab Disord       Date:  2014-03       Impact factor: 6.514

8.  KDM4A Coactivates E2F1 to Regulate the PDK-Dependent Metabolic Switch between Mitochondrial Oxidation and Glycolysis.

Authors:  Ling-Yu Wang; Chiu-Lien Hung; Yun-Ru Chen; Joy C Yang; Junjian Wang; Mel Campbell; Yoshihiro Izumiya; Hong-Wu Chen; Wen-Ching Wang; David K Ann; Hsing-Jien Kung
Journal:  Cell Rep       Date:  2016-09-13       Impact factor: 9.423

9.  E4F1 controls a transcriptional program essential for pyruvate dehydrogenase activity.

Authors:  Matthieu Lacroix; Geneviève Rodier; Olivier Kirsh; Thibault Houles; Hélène Delpech; Berfin Seyran; Laurie Gayte; Francois Casas; Laurence Pessemesse; Maud Heuillet; Floriant Bellvert; Jean-Charles Portais; Charlene Berthet; Florence Bernex; Michele Brivet; Audrey Boutron; Laurent Le Cam; Claude Sardet
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-12       Impact factor: 11.205

10.  Phase 1 trial of dichloroacetate (DCA) in adults with recurrent malignant brain tumors.

Authors:  E M Dunbar; B S Coats; A L Shroads; T Langaee; A Lew; J R Forder; J J Shuster; D A Wagner; P W Stacpoole
Journal:  Invest New Drugs       Date:  2013-12-03       Impact factor: 3.850

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.